Liang Pei , Zhuo Yao , Dong Liang , Keda Yang , Lin Tao
{"title":"Mitochondria in skeletal system-related diseases","authors":"Liang Pei , Zhuo Yao , Dong Liang , Keda Yang , Lin Tao","doi":"10.1016/j.biopha.2024.117505","DOIUrl":null,"url":null,"abstract":"<div><div>Skeletal system-related diseases, such as osteoporosis, arthritis, osteosarcoma and sarcopenia, are becoming major public health concerns. These diseases are characterized by insidious progression, which seriously threatens patients’ health and quality of life. Early diagnosis and prevention in high-risk populations can effectively prevent the deterioration of these patients. Mitochondria are essential organelles for maintaining the physiological activity of the skeletal system. Mitochondrial functions include contributing to the energy supply, modulating the Ca<sup>2+</sup> concentration, maintaining redox balance and resisting the inflammatory response. They participate in the regulation of cellular behaviors and the responses of osteoblasts, osteoclasts, chondrocytes and myocytes to external stimuli. In this review, we describe the pathogenesis of skeletal system diseases, focusing on mitochondrial function. In addition to osteosarcoma, a characteristic of which is active mitochondrial metabolism, mitochondrial damage occurs during the development of other diseases. Impairment of mitochondria leads to an imbalance in osteogenesis and osteoclastogenesis in osteoporosis, cartilage degeneration and inflammatory infiltration in arthritis, and muscle atrophy and excitation<img>contraction coupling blockade in sarcopenia. Overactive mitochondrial metabolism promotes the proliferation and migration of osteosarcoma cells. The copy number of mitochondrial DNA and mitochondria-derived peptides can be potential biomarkers for the diagnosis of these disorders. High-risk factor detection combined with mitochondrial component detection contributes to the early detection of these diseases. Targeted mitochondrial intervention is an effective method for treating these patients. We analyzed skeletal system-related diseases from the perspective of mitochondria and provided new insights for their diagnosis, prevention and treatment by demonstrating the relationship between mitochondria and the skeletal system.</div></div>","PeriodicalId":8966,"journal":{"name":"Biomedicine & Pharmacotherapy","volume":"181 ","pages":"Article 117505"},"PeriodicalIF":6.9000,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomedicine & Pharmacotherapy","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S075333222401391X","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
Abstract
Skeletal system-related diseases, such as osteoporosis, arthritis, osteosarcoma and sarcopenia, are becoming major public health concerns. These diseases are characterized by insidious progression, which seriously threatens patients’ health and quality of life. Early diagnosis and prevention in high-risk populations can effectively prevent the deterioration of these patients. Mitochondria are essential organelles for maintaining the physiological activity of the skeletal system. Mitochondrial functions include contributing to the energy supply, modulating the Ca2+ concentration, maintaining redox balance and resisting the inflammatory response. They participate in the regulation of cellular behaviors and the responses of osteoblasts, osteoclasts, chondrocytes and myocytes to external stimuli. In this review, we describe the pathogenesis of skeletal system diseases, focusing on mitochondrial function. In addition to osteosarcoma, a characteristic of which is active mitochondrial metabolism, mitochondrial damage occurs during the development of other diseases. Impairment of mitochondria leads to an imbalance in osteogenesis and osteoclastogenesis in osteoporosis, cartilage degeneration and inflammatory infiltration in arthritis, and muscle atrophy and excitationcontraction coupling blockade in sarcopenia. Overactive mitochondrial metabolism promotes the proliferation and migration of osteosarcoma cells. The copy number of mitochondrial DNA and mitochondria-derived peptides can be potential biomarkers for the diagnosis of these disorders. High-risk factor detection combined with mitochondrial component detection contributes to the early detection of these diseases. Targeted mitochondrial intervention is an effective method for treating these patients. We analyzed skeletal system-related diseases from the perspective of mitochondria and provided new insights for their diagnosis, prevention and treatment by demonstrating the relationship between mitochondria and the skeletal system.
与骨骼系统相关的疾病,如骨质疏松症、关节炎、骨肉瘤和肌肉疏松症,正在成为公众健康的主要问题。这些疾病具有隐匿性进展的特点,严重威胁患者的健康和生活质量。对高危人群进行早期诊断和预防,可以有效防止这些患者的病情恶化。线粒体是维持骨骼系统生理活动的重要细胞器。线粒体的功能包括提供能量、调节 Ca2+ 浓度、维持氧化还原平衡和抵抗炎症反应。它们参与调节细胞行为以及成骨细胞、破骨细胞、软骨细胞和肌细胞对外界刺激的反应。在这篇综述中,我们将以线粒体功能为重点,描述骨骼系统疾病的发病机理。骨肉瘤的一个特点是线粒体代谢活跃,除骨肉瘤外,线粒体损伤也发生在其他疾病的发展过程中。线粒体受损会导致骨质疏松症中的成骨和破骨细胞生成失衡、关节炎中的软骨退化和炎症浸润,以及肌肉疏松症中的肌肉萎缩和兴奋-收缩耦联阻断。过度活跃的线粒体代谢会促进骨肉瘤细胞的增殖和迁移。线粒体 DNA 的拷贝数和线粒体衍生肽可作为诊断这些疾病的潜在生物标记物。高危因素检测与线粒体成分检测相结合,有助于早期发现这些疾病。有针对性的线粒体干预是治疗这些患者的有效方法。我们从线粒体的角度分析了骨骼系统相关疾病,通过展示线粒体与骨骼系统之间的关系,为这些疾病的诊断、预防和治疗提供了新的见解。
期刊介绍:
Biomedicine & Pharmacotherapy stands as a multidisciplinary journal, presenting a spectrum of original research reports, reviews, and communications in the realms of clinical and basic medicine, as well as pharmacology. The journal spans various fields, including Cancer, Nutriceutics, Neurodegenerative, Cardiac, and Infectious Diseases.